Advertisement

Topics

U.S. HIV/AIDS Diagnostic Testing Market 2021: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares and Country Forecasts [Report Updated: 06072017] Prices from USD $2300

07:07 EDT 9 Aug 2017 | BioPortfolio Reports

Complete report $2,300.nbsp; DataPack test volumes, sales forecasts, supplier shares $1,500.

Summary

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLVI/II and other confirmatory tests performed in the following market segments:

nbsp;nbsp;nbsp;nbsp; Hospitals
nbsp;nbsp;nbsp;nbsp; Commercial/Private Laboratories
nbsp;nbsp;nbsp;nbsp; Blood Banks
nbsp;nbsp;nbsp;nbsp; Physician Offices
nbsp;nbsp;nbsp;nbsp; Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, OrthoClinical Diagnostics/Jamp;J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearchrsquo;s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary singleclient assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 6 tables

Original Article: U.S. HIV/AIDS Diagnostic Testing Market 2021: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares and Country Forecasts [Report Updated: 06072017] Prices from USD $2300

NEXT ARTICLE

More From BioPortfolio on "U.S. HIV/AIDS Diagnostic Testing Market 2021: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares and Country Forecasts [Report Updated: 06072017] Prices from USD $2300"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...